← FDA Drug Approvals (Drugs@FDA)

OLMESARTAN MEDOXOMIL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UMEDICA · Approved 2019-07-18

Drug application

FDA Application #

ANDA207135

Application type

Abbreviated New Drug Application (Generic)

Brand name

OLMESARTAN MEDOXOMIL

Generic name

OLMESARTAN MEDOXOMIL

Active ingredients

OLMESARTAN MEDOXOMIL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

UMEDICA

Manufacturer

Lifestar Pharma LLC

First approval

2019-07-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown